Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Jul;12(1):114-23.
doi: 10.1128/JVI.12.1.114-123.1973.

Antigenic determinants of infective and inactivated human rhinovirus type 2

Antigenic determinants of infective and inactivated human rhinovirus type 2

K Lonberg-Holm et al. J Virol. 1973 Jul.

Abstract

Treatment of human rhinovirus type 2 (HRV 2) virions at pH 5, at 56 C or in 2 M urea, produces one or both of two types of subviral particles. These subviral particles sediment at 135S or at 80S and both share what have been designated as C-antigenic determinants; the determinants of native virions have been designated D. These sets of determinants have been contrasted by the techniques of immunodiffusion, complement fixation, and serum blocking, and the results indicate that many or most of the D-determinants are lost in the conversion to C antigenicity. Some of the HRV 2 C-determinants also react, in immunodiffusion and in complement fixation tests, with antisera produced against HRV 1A virions. The inverse reaction has also been detected by complement fixation. Purified natural top component (NTC) of HRV 2 contains C- and, to a lesser extent, D-determinants. The D-determinants of NTC are also, like those of virions, lost upon treatment at pH 5. These results are discussed in terms of a conformational model for the D- to C-antigenic conversion.

PubMed Disclaimer

References

    1. J Virol. 1973 Jul;12(1):108-13 - PubMed
    1. Br Med J. 1948 Mar 13;1(4549):493-6 - PubMed
    1. J Gen Virol. 1969 Jun;4(4):479-87 - PubMed
    1. J Immunol. 1958 Nov;81(5):419-25 - PubMed
    1. J Immunol. 1965 Apr;94:482-91 - PubMed

LinkOut - more resources